NASDAQ:HUMA

Humacyte Stock Insider Trading

etoro logo Buy HUMA
*Your capital is at risk
$0.84
-0.0851 (-9.21%)
At Close: Jun 22, 2026

Humacyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -74.51. In total, the insiders bought 11.3M and sold 10.43M HUMA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-74.51
Buy 11.3M shares
Sell 10.43M shares
82% Buy Activity
Moderate Positive Correlation
Buy Signal Low Confidence
Jun 11, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -74.51.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (82% buys).

Historical Insider Trades

Date Type Person Role Amount
Aug 19, 2025
Sell
Common Stock
S-Sale
Niklason Laura E
President, CEO And Director
CEO / President 1 100 000
Value: $1.79M
Aug 19, 2025
Sell
Common Stock
S-Sale
Dougan Brady W
Director
Director 1 100 000
Value: $1.79M
Aug 18, 2025
Sell
Common Stock
S-Sale
Dougan Brady W
Director
Director 549 360
Value: $1.01M
Aug 18, 2025
Sell
Common Stock
S-Sale
Niklason Laura E
President, CEO And Director
CEO / President 549 360
Value: $1.01M
Aug 18, 2025
Sell
Common Stock
S-Sale
Niklason Laura E
President, CEO And Director
CEO / President 549 360
Value: $1.01M
Aug 18, 2025
Sell
Common Stock
S-Sale
Dougan Brady W
Director
Director 549 360
Value: $1.01M
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Pope Todd
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Brown Emery N.
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Jones Keith Anthony
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Wallace Max N.
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Windham-bannister Susan Richards
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Niklason Laura E
President, CEO And Director
CEO / President 0
Value: $0
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Dougan Brady W
Director
Director 0
Value: $0
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Green Charles Bruce
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Constantino Michael T.
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Bamforth John Philip
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Seimetz Diane
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Sebelius Kathleen
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Sebelius Kathleen
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Seimetz Diane
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Bamforth John Philip
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Constantino Michael T.
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Green Charles Bruce
Director
Director 80 000
Value: $192.8K
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Dougan Brady W
Director
Director 0
Value: $0
Jun 12, 2025
Buy
Stock Options (right to buy)
A-Award
Niklason Laura E
President, CEO And Director
CEO / President 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HUMACYTE, INC.
Humacyte
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without i...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE